Cargando…
A bio-analytically validated HPLC-UV method for simultaneous determination of doripenem and ertapenem in pharmaceutical dosage forms and human plasma: a dual carbapenem regimen for treatment of drug-resistant strain of Klebsiella pneumoniae
The emergence of strains resistant to certain antibiotics is turning into an important issue worldwide that threatens global health with the increasing incidence of carbapenemase-producing Klebsiella pneumoniae (KPC). Thus, successful doripenem–ertapenem (DOR–ERTA) combination is highly recommended...
Autores principales: | Ali, Marwa F. B., Marzouq, Mostafa A., Hussein, Samiha A., Salman, Baher I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134031/ https://www.ncbi.nlm.nih.gov/pubmed/35747078 http://dx.doi.org/10.1039/d0ra10466c |
Ejemplares similares
-
Highly sensitive cadmium sulphide quantum dots as a fluorescent probe for estimation of doripenem in real human plasma: application to pharmacokinetic study
por: Ali, Marwa F. B., et al.
Publicado: (2020) -
HPLC/UV approach method for the first simultaneous estimation of molnupiravir and ertapenem as a binary mixture in human plasma and dosage form as a regimen for COVID-19 treatments
por: Afify, Khaled K., et al.
Publicado: (2023) -
Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens
por: Oesterreicher, Zoe, et al.
Publicado: (2017) -
Molecular epidemiology and mechanism of Klebsiella pneumoniae resistance to ertapenem but not to other carbapenems in China
por: Wang, Dongliang, et al.
Publicado: (2022) -
Corrigendum: Molecular epidemiology and mechanism of Klebsiella pneumoniae resistance to ertapenem but not to other carbapenems in China
por: Wang, Dongliang, et al.
Publicado: (2023)